Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is alprolix?

See the DrugPatentWatch profile for alprolix

What is Alprolix?

Alprolix (eftrenonacog alfa) is a gene-activated recombinant clotting factor IX medicine used to treat hemophilia B. It replaces the missing or faulty factor IX that people with hemophilia B need to form blood clots. [1]

What condition is it used for?

Alprolix is prescribed for people with hemophilia B. It’s used to prevent bleeding episodes (prophylaxis) and to treat bleeding when they occur (on-demand treatment), because it supplies functional factor IX activity. [1]

Is it the same as other factor IX products?

Alprolix is a specific type of recombinant factor IX product (eftrenonacog alfa). Other hemophilia B treatments may include different factor IX products or different dosing schedules, but Alprolix is one branded option within factor IX therapies. [1]

Who makes it and where can I read more?

One place to check for manufacturer and product details, including patent and market information, is DrugPatentWatch.com. [1]

Sources

[1] https://www.drugpatentwatch.com/drugs/alprolix/



Other Questions About Alprolix :

alprolix worldwide approval prolixin vs alprolix alprolix infusion what is the latest us regulatory outcome for alprolix (eftrenonacog alfa) by bioverativ/swedish orphan biovitrum? alprolix pediatric data Alprolix infusion? Alprolix prescribing information?